EU Strikes Deal With Moderna to Rush COVID-19 Vaccine Supplies to Germany

(Reuters) – The European Commission said on Thursday it has reached an agreement with Moderna to rush deliveries of the U.S. company’s COVID-19 vaccine to Germany and other European Union member states, as cases surge due to the Omicron variant.

Governments across Europe are struggling with soaring infections, with some regions imposing restrictions to curb the spread of the Omicron variant of the coronavirus.

“In view of the rapid increase in infections due to the Omicron variant, and the need to scale up vaccination, including boosting, the Commission is working with vaccine manufacturers to further accelerate the delivery of vaccine doses,” the EC said.

Moderna expects to deliver 10 million doses of its mRNA-based vaccine to Germany in December, with delivery of 25 million extra doses expected in the first quarter of 2022, the European Union’s executive body said in a statement.

The news comes after Germany’s health ministry on Wednesday warned that vaccine deliveries into Europe’s largest economy would drop sharply in the first quarter of next year, but it denied a report that the shortfall would reach 60 million doses.

Germany also said it would spend an additional 2.2 billion euros ($2.49 billion) to procure COVID-19 vaccines, as shots are urgently needed amid the fourth wave of infections.

Further acceleration of deliveries by Moderna is being prepared for the first quarter of 2022, to the benefit of additional member states, the EC added.

($1 = 0.8826 euros)

Source: Read Full Article